The novel [1,2,4] triazolo [1,5- a ] pyridinyl-6-yl substituted tetrahydroisoquinolines are described herein. These compounds and crystalline forms SA1 and N-2 are used for the treatment of various neurological and physiological disorders. Methods for producing these compounds and crystalline SA-1 and N-2 are also described in the present invention.